Kymera Therapeutic

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Kymera Therapeutic 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About KYMR

Kymera Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of human diseases through the development of innovative, highly differentiated medicines. It focuses on discovering and developing novel small-molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s natural protein degradation system. 

CEO
Nello Mainolfi
CEONello Mainolfi
Employees
238
Employees238
Headquarters
Watertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded
2015
Founded2015
Employees
238
Employees238

KYMR Key Statistics

Market cap
6.66B
Market cap6.66B
Price-Earnings ratio
-22.99
Price-Earnings ratio-22.99
Dividend yield
—
Dividend yield—
Average volume
918.05K
Average volume918.05K
High today
$84.56
High today$84.56
Low today
$81.43
Low today$81.43
Open price
$83.51
Open price$83.51
Volume
682.68K
Volume682.68K
52 Week high
$103.00
52 Week high$103.00
52 Week low
$19.45
52 Week low$19.45

Stock Snapshot

With a market cap of 6.66B, Kymera Therapeutic(KYMR) trades at $81.52. The stock has a price-to-earnings ratio of -22.99.

During the trading session on 2026-03-11, Kymera Therapeutic(KYMR) shares reached a daily high of $84.56 and a low of $81.43. At a current price of $81.52, the stock is +0.1% higher than the low and still -3.6% under the high.

Trading activity shows a volume of 682.68K, compared to an average daily volume of 918.05K.

Over the past 52 weeks, Kymera Therapeutic(KYMR) stock has traded between a high of $103.00 and a low of $19.45.

Over the past 52 weeks, Kymera Therapeutic(KYMR) stock has traded between a high of $103.00 and a low of $19.45.

Analyst ratings

92%

of 24 ratings
Buy
91.7%
Hold
4.2%
Sell
4.2%

People also own

Based on the portfolios of people who own KYMR. This list is generated using Robinhood data, and it’s not a recommendation.
Taiwan Semiconductor Manu…
Micron Technology
CRISPR
AMD
Pfizer
Palantir Technologies

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.